Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Jan 2022 Mar Drugs New Deoxyenhygrolides from Plesiocystis pacifica Provide Insights into Butenolide Core Biosynthesis Autoren Hug JJ et al. Jan 2022 PLoS One RNA reference materials with defined viral RNA loads of SARS-CoV-2-A useful tool towards a better PCR assay harmonization Autoren Vierbaum L et al. Jan 2022 Acta Trop Schistosomiasis in Gabon from 2000 to 2021 - A review Autoren Dejon-Agobé JC et al. Jan 2022 Elife Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF Autoren Slavetinsky CJ et al. Jan 2022 Lancet Infect Dis Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalized adults with bloodstream infections: a multicentre, prospective, cohort study Autoren Tacconelli E Göpel S Gladstone BP ... Jan 2022 Lancet Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Autoren Antimicrobial Resistance Collaborators et al. Jan 2022 mBio Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection Autoren Shin DL et al. Jan 2022 Internist (Berl) [Practical use of digital health applications (DiGA) in internal medicine] Autoren Mittermaier M et al. Jan 2022 Infect Genet Evol Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014-2017 Autoren Tabatabai J et al. Jan 2022 Euro Surveill Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January−December 2016 Autoren Biehl LM et al. Jan 2022 PLoS One Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study Autoren Biehl LM et al. Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect] Autoren Nkongolo S Hollnberger J Urban S Jan 2022 PLoS Pathog Advances and gaps in SARS-CoV-2 infection models Autoren Muñoz-Fontela C et al. Jan 2022 Mol ther Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors Autoren Becker J et al. Jan 2022 Commun Biol SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Autoren Neufeldt CJ et al. Jan 2022 Chem Sci Total synthesis and mechanism of action of the antibiotic armeniaspirol A Autoren Arisetti N et al. Jan 2022 Clin Exp Immunol Deciphering the Plasmodium falciparum malaria-specific CD4+ T cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer Autoren Schulte S et al. Jan 2022 PLoS Pathog Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection Autoren Sohail A et al. Jan 2022 J Virol Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors Autoren Richter E et al. Jan 2022 J Antimicrob Chemother An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones Autoren Vehreschild M et al. Jan 2022 Nat Commun Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Autoren Koerber N et al. Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T Jan 2022 Parasitol Res A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs Autoren Schlabe S et al. Jan 2022 Hepatology HCC and HBV reactivation-A preventable condition not to be missed Autoren Sandmann L Cornberg M Jan 2022 Bioorg Med Chem Lett Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part Autoren Megahed SH et al. Pagination Previous page ‹‹ Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Seite 35 Seite 36 Current page 37 Seite 38 Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Seite 35 Seite 36 Seite 37 Seite 38 Next page ››
Jan 2022 Mar Drugs New Deoxyenhygrolides from Plesiocystis pacifica Provide Insights into Butenolide Core Biosynthesis Autoren Hug JJ et al.
Jan 2022 PLoS One RNA reference materials with defined viral RNA loads of SARS-CoV-2-A useful tool towards a better PCR assay harmonization Autoren Vierbaum L et al.
Jan 2022 Acta Trop Schistosomiasis in Gabon from 2000 to 2021 - A review Autoren Dejon-Agobé JC et al.
Jan 2022 Elife Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF Autoren Slavetinsky CJ et al.
Jan 2022 Lancet Infect Dis Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalized adults with bloodstream infections: a multicentre, prospective, cohort study Autoren Tacconelli E Göpel S Gladstone BP ...
Jan 2022 Lancet Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Autoren Antimicrobial Resistance Collaborators et al.
Jan 2022 mBio Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection Autoren Shin DL et al.
Jan 2022 Internist (Berl) [Practical use of digital health applications (DiGA) in internal medicine] Autoren Mittermaier M et al.
Jan 2022 Infect Genet Evol Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014-2017 Autoren Tabatabai J et al.
Jan 2022 Euro Surveill Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January−December 2016 Autoren Biehl LM et al.
Jan 2022 PLoS One Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study Autoren Biehl LM et al.
Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect] Autoren Nkongolo S Hollnberger J Urban S
Jan 2022 Mol ther Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors Autoren Becker J et al.
Jan 2022 Commun Biol SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Autoren Neufeldt CJ et al.
Jan 2022 Chem Sci Total synthesis and mechanism of action of the antibiotic armeniaspirol A Autoren Arisetti N et al.
Jan 2022 Clin Exp Immunol Deciphering the Plasmodium falciparum malaria-specific CD4+ T cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer Autoren Schulte S et al.
Jan 2022 PLoS Pathog Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection Autoren Sohail A et al.
Jan 2022 J Virol Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors Autoren Richter E et al.
Jan 2022 J Antimicrob Chemother An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones Autoren Vehreschild M et al.
Jan 2022 Nat Commun Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Autoren Koerber N et al.
Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T
Jan 2022 Parasitol Res A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs Autoren Schlabe S et al.
Jan 2022 Hepatology HCC and HBV reactivation-A preventable condition not to be missed Autoren Sandmann L Cornberg M
Jan 2022 Bioorg Med Chem Lett Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part Autoren Megahed SH et al.
